A detailed history of Allworth Financial LP transactions in Amgen Inc stock. As of the latest transaction made, Allworth Financial LP holds 25,033 shares of AMGN stock, worth $6.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,033
Previous 24,248 3.24%
Holding current value
$6.59 Million
Previous $7.58 Million 6.45%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $242,863 - $264,843
785 Added 3.24%
25,033 $8.07 Million
Q2 2024

Jul 23, 2024

BUY
$262.75 - $319.31 $1.89 Million - $2.3 Million
7,198 Added 42.22%
24,248 $7.58 Million
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $149,760 - $180,779
557 Added 3.38%
17,050 $4.85 Million
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $161,346 - $182,018
-631 Reduced 3.68%
16,493 $4.75 Million
Q3 2023

Oct 31, 2023

SELL
$218.65 - $271.46 $47,665 - $59,178
-218 Reduced 1.26%
17,124 $4.6 Million
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $142,918 - $168,997
667 Added 4.0%
17,342 $3.85 Million
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $305,945 - $372,896
1,355 Added 8.84%
16,675 $4.03 Million
Q4 2022

Jan 13, 2023

BUY
$229.03 - $291.01 $181,162 - $230,188
791 Added 5.44%
15,320 $0
Q3 2022

Oct 18, 2022

BUY
$224.46 - $253.15 $255,211 - $287,831
1,137 Added 8.49%
14,529 $3.28 Million
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $487,951 - $543,005
2,115 Added 18.75%
13,392 $3.26 Million
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $1.43 Million - $1.58 Million
6,517 Added 136.91%
11,277 $2.73 Million
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $43,753 - $50,072
-220 Reduced 4.42%
4,760 $1.07 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $451,286 - $528,736
2,126 Added 74.49%
4,980 $1.06 Million
Q2 2021

Aug 02, 2021

SELL
$233.58 - $259.14 $39,475 - $43,794
-169 Reduced 5.59%
2,854 $696,000
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $75,005 - $87,406
338 Added 12.59%
3,023 $752,000
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $6,924 - $8,245
32 Added 1.21%
2,685 $617,000
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $42,002 - $46,710
-179 Reduced 6.32%
2,653 $674,000
Q2 2020

Jul 24, 2020

SELL
$197.81 - $242.74 $395 - $485
-2 Reduced 0.07%
2,832 $668,000
Q1 2020

Apr 17, 2020

BUY
$182.24 - $241.7 $102,601 - $136,077
563 Added 24.79%
2,834 $575,000
Q4 2019

Jan 16, 2020

BUY
$189.21 - $243.2 $57,519 - $73,932
304 Added 15.46%
2,271 $547,000
Q3 2019

Oct 09, 2019

BUY
$174.11 - $208.62 $6,790 - $8,136
39 Added 2.02%
1,967 $381,000
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $2,532 - $2,854
14 Added 0.73%
1,928 $366,000
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $356 - $416
2 Added 0.1%
1,914 $373,000
Q3 2018

Oct 30, 2018

SELL
$185.29 - $208.89 $24,643 - $27,782
-133 Reduced 6.5%
1,912 $396,000
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $25,073 - $28,163
151 Added 7.97%
2,045 $377,000
Q1 2018

May 02, 2018

BUY
$169.43 - $198.0 $14,232 - $16,632
84 Added 4.64%
1,894 $323,000
Q4 2017

Feb 22, 2018

SELL
$168.79 - $188.59 $54,350 - $60,725
-322 Reduced 15.1%
1,810 $315,000
Q3 2017

Oct 12, 2017

SELL
$167.29 - $191.0 $10,539 - $12,033
-63 Reduced 2.87%
2,132 $398,000
Q2 2017

Aug 07, 2017

BUY
N/A
2,195
2,195 $378,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.